Trials / Completed
CompletedNCT01129596
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,238 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the following about donepezil hydrochloride administration in patients with mild or moderate Alzheimer's Disease in clinical practice: cognitive function, Functional Assessment Staging (FAST) score, adverse events/adverse drug reactions, and patient background.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | donepezil hydrochloride | This is a multicenter, open-labeled, practice-based, post-marketing surveillance study. Therefore, dosing is not specified. |
Timeline
- Start date
- 2010-06-10
- Primary completion
- 2015-09-25
- Completion
- 2016-06-23
- First posted
- 2010-05-24
- Last updated
- 2018-11-05
Locations
722 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01129596. Inclusion in this directory is not an endorsement.